A novel SARS-CoV-2 subunit vaccine engineered on an immune-activating platform technology

por Quinlan, Edward J., Chubet, Richard, Leonardi, Peter
Publicado 2022

Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine

por Wang, Keyang, Holtz, Kathleen M., Anderson, Karl, Chubet, Richard, Mahmoud, Wafaa, Cox, Manon M.J.
Publicado 2006

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant

por McPherson, Clifton, Chubet, Richard, Holtz, Kathy, Honda-Okubo, Yoshikazu, Barnard, Dale, Cox, Manon, Petrovsky, Nikolai
Publicado 2015